ETF Holdings Breakdown of HAE

Stock Name	Haemonetics Corporation
Ticker	HAE(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US4050241003
LEI	549300ZEL6TXZS6F5F95

HAE institutional holdings

The adjusted close for HAE on 2025-11-12 was 73.12

The following institutional investment holdings of HAE have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-12 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 34,006 USD 2,486,519 1.9% 73.12

2025-11-12 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 35,698 -0.3% USD 2,610,238 1.6% 73.12

2025-11-12 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 969 USD 70,853 1.9% 73.12

Total = 70,673 USD 5,167,610
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2025-11-12	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	34,006	USD 2,486,519 1.9%	73.12
2025-11-12	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	35,698 -0.3%	USD 2,610,238 1.6%	73.12
2025-11-12	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	969	USD 70,853 1.9%	73.12
Total =	70,673	USD 5,167,610

News associated with HAE

Haemonetics Corporation (NYSE:HAE) Short Interest Up 41.9% in August: Haemonetics Corporation (NYSE:HAE – Get Free Report) was the recipient of a large growth in short interest during the month of August. As of August 15th, there was short interest totaling 4,370,000 shares, a growth of 41.9% from the July 31st total of 3,080,000 shares. Approximately 9.2% of the company’s stock are short sold. Based […] - 2025-09-10 04:58:58
Haemonetics (NYSE:HAE) Price Target Lowered to $70.00 at Mizuho: Haemonetics (NYSE:HAE – Free Report) had its target price reduced by Mizuho from $90.00 to $70.00 in a research report released on Friday,Benzinga reports. They currently have an outperform rating on the medical instruments supplier’s stock. A number of other equities analysts also recently commented on the stock. Raymond James Financial reiterated a “strong-buy” rating […] - 2025-08-11 02:56:42
Brokerages Set Haemonetics Corporation (NYSE:HAE) Target Price at $97.30: Shares of Haemonetics Corporation (NYSE:HAE – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eleven analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eight have given a buy recommendation and two have assigned a strong buy recommendation […] - 2025-08-06 02:30:53
Arizona State Retirement System Trims Position in Haemonetics Corporation (NYSE:HAE): Arizona State Retirement System cut its holdings in shares of Haemonetics Corporation (NYSE:HAE – Free Report) by 3.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 14,407 shares of the medical instruments supplier’s stock after selling 446 shares during the quarter. Arizona State Retirement System’s holdings in Haemonetics were worth $916,000 at […] - 2025-07-21 06:12:11
Principal Financial Group Inc. Acquires 2,160 Shares of Haemonetics Corporation (NYSE:HAE): Principal Financial Group Inc. lifted its stake in Haemonetics Corporation (NYSE:HAE – Free Report) by 1.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 158,894 shares of the medical instruments supplier’s stock after purchasing an additional 2,160 shares during […] - 2025-07-15 05:12:49
Haemonetics (NYSE:HAE) Raised to Buy at Citigroup: Haemonetics (NYSE:HAE – Get Free Report) was upgraded by stock analysts at Citigroup from a “neutral” rating to a “buy” rating in a research note issued to investors on Wednesday, MarketBeat.com reports. The brokerage presently has a $90.00 target price on the medical instruments supplier’s stock. Citigroup’s target price points to a potential upside of […] - 2025-07-11 02:20:48
Haemonetics Corporation (NYSE:HAE) Receives Average Rating of “Moderate Buy” from Brokerages: Shares of Haemonetics Corporation (NYSE:HAE – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven research firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, seven have given a buy recommendation and two […] - 2025-07-09 04:53:34
KBC Group NV Grows Holdings in Haemonetics Corporation (NYSE:HAE): KBC Group NV raised its position in Haemonetics Corporation (NYSE:HAE – Free Report) by 19.9% during the first quarter, Holdings Channel.com reports. The firm owned 2,417 shares of the medical instruments supplier’s stock after buying an additional 401 shares during the period. KBC Group NV’s holdings in Haemonetics were worth $154,000 at the end of […] - 2025-07-07 04:48:46
Vontobel Holding Ltd. Has $1.01 Million Holdings in Haemonetics Corporation (NYSE:HAE): Vontobel Holding Ltd. increased its position in shares of Haemonetics Corporation (NYSE:HAE – Free Report) by 21.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,839 shares of the medical instruments supplier’s stock after acquiring an additional 2,828 shares during the period. Vontobel […] - 2025-07-06 06:01:06
Haemonetics Co. (NYSE:HAE) Shares Bought by Rhumbline Advisers: Rhumbline Advisers increased its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 1.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 161,123 shares of the medical instruments supplier’s stock after acquiring an additional 1,861 shares during […] - 2025-06-10 04:54:58
Two Sigma Investments LP Decreases Holdings in Haemonetics Co. (NYSE:HAE): Two Sigma Investments LP trimmed its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 24.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 58,799 shares of the medical instruments supplier’s stock after selling 18,675 shares during the quarter. Two Sigma Investments LP’s holdings in Haemonetics were worth $4,591,000 at the end […] - 2025-05-28 05:52:51
Nuveen Asset Management LLC Lowers Stock Holdings in Haemonetics Co. (NYSE:HAE): Nuveen Asset Management LLC lowered its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 11.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 161,452 shares of the medical instruments supplier’s stock after selling 19,887 shares during the quarter. […] - 2025-05-27 04:44:56
Analysts Set Haemonetics Co. (NYSE:HAE) PT at $97.89: Shares of Haemonetics Co. (NYSE:HAE – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation, six have issued a buy recommendation and […] - 2025-05-23 03:14:52
Nomura Holdings Inc. Invests $519,000 in Haemonetics Co. (NYSE:HAE): Nomura Holdings Inc. purchased a new position in Haemonetics Co. (NYSE:HAE – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 6,652 shares of the medical instruments supplier’s stock, valued at approximately $519,000. A number of other hedge funds have also recently made changes […] - 2025-05-22 06:48:56
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,084 Shares of Haemonetics Co. (NYSE:HAE): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 3.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,570 shares of the medical instruments supplier’s stock after purchasing an additional 1,084 shares during the […] - 2025-05-22 05:50:49
Captrust Financial Advisors Grows Position in Haemonetics Co. (NYSE:HAE): Captrust Financial Advisors raised its position in Haemonetics Co. (NYSE:HAE – Free Report) by 14.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,872 shares of the medical instruments supplier’s stock after purchasing an additional 624 shares during the […] - 2025-05-20 04:50:49
Haemonetics (NYSE:HAE) Lowered to “Hold” Rating by StockNews.com: Haemonetics (NYSE:HAE – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Tuesday. HAE has been the topic of several other reports. Bank of America lowered Haemonetics from a “neutral” rating to an “underperform” rating and cut their target price […] - 2025-05-15 02:56:49
Schonfeld Strategic Advisors LLC Reduces Position in Haemonetics Co. (NYSE:HAE): Schonfeld Strategic Advisors LLC lessened its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 13.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,266 shares of the medical instruments supplier’s stock after selling 672 shares during the period. […] - 2025-05-13 05:38:48
Stifel Financial Corp Grows Position in Haemonetics Co. (NYSE:HAE): Stifel Financial Corp lifted its position in Haemonetics Co. (NYSE:HAE – Free Report) by 7.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,776 shares of the medical instruments supplier’s stock after purchasing an additional 1,006 shares during the quarter. Stifel […] - 2025-05-09 05:26:56
Analysts Set Haemonetics Co. (NYSE:HAE) Price Target at $101.22: Haemonetics Co. (NYSE:HAE – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation, six have given a buy recommendation and one has issued […] - 2025-04-28 02:39:01
Envestnet Asset Management Inc. Buys 4,217 Shares of Haemonetics Co. (NYSE:HAE): Envestnet Asset Management Inc. boosted its stake in Haemonetics Co. (NYSE:HAE – Free Report) by 9.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 48,068 shares of the medical instruments supplier’s stock after purchasing an additional 4,217 shares during the […] - 2025-04-25 04:40:56
Bank of Montreal Can Sells 12,518,398 Shares of Haemonetics Co. (NYSE:HAE): Bank of Montreal Can decreased its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 99.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 7,933 shares of the medical instruments supplier’s stock after selling 12,518,398 shares during the quarter. Bank of Montreal Can’s holdings in Haemonetics were worth $619,000 as of […] - 2025-04-21 05:18:52
Federated Hermes Inc. Trims Holdings in Haemonetics Co. (NYSE:HAE): Federated Hermes Inc. reduced its holdings in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 10.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,554 shares of the medical instruments supplier’s stock after selling 436 shares during the period. Federated Hermes Inc.’s holdings in Haemonetics […] - 2025-04-18 04:59:07
Haemonetics Co. (NYSE:HAE) Holdings Raised by Pictet Asset Management Holding SA: Pictet Asset Management Holding SA lifted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 16.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,963 shares of the medical instruments supplier’s stock after acquiring an additional 979 […] - 2025-04-09 05:42:56
KLP Kapitalforvaltning AS Makes New Investment in Haemonetics Co. (NYSE:HAE): KLP Kapitalforvaltning AS acquired a new stake in Haemonetics Co. (NYSE:HAE – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund acquired 10,100 shares of the medical instruments supplier’s stock, valued at approximately $789,000. A number of other hedge funds also recently modified their holdings of HAE. Wellington Management Group LLP raised its […] - 2025-04-01 05:14:58
15,294 Shares in Haemonetics Co. (NYSE:HAE) Bought by Natixis Advisors LLC: Natixis Advisors LLC acquired a new stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund acquired 15,294 shares of the medical instruments supplier’s stock, valued at approximately $1,194,000. A number of other hedge funds have also recently modified their holdings of HAE. Parkside Financial Bank […] - 2025-03-26 05:54:45
Zurcher Kantonalbank Zurich Cantonalbank Acquires 1,202 Shares of Haemonetics Co. (NYSE:HAE): Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Haemonetics Co. (NYSE:HAE – Free Report) by 10.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,460 shares of the medical instruments supplier’s stock after acquiring an additional 1,202 shares during the period. Zurcher […] - 2025-03-21 06:08:54
Needham & Company LLC Has Lowered Expectations for Haemonetics (NYSE:HAE) Stock Price: Haemonetics (NYSE:HAE – Get Free Report) had its target price cut by stock analysts at Needham & Company LLC from $108.00 to $104.00 in a report issued on Tuesday, Marketbeat reports. The brokerage currently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s target price indicates a potential upside of […] - 2025-03-20 04:28:54
Haemonetics Co. (NYSE:HAE) Shares Bought by AlphaQuest LLC: AlphaQuest LLC boosted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 36,520.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 1,831 shares of the medical instruments supplier’s stock after acquiring an additional 1,826 shares during the quarter. AlphaQuest LLC’s holdings […] - 2025-03-18 06:06:52
Haemonetics Co. (NYSE:HAE) Shares Sold by State of Michigan Retirement System: State of Michigan Retirement System decreased its stake in Haemonetics Co. (NYSE:HAE – Free Report) by 2.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,874 shares of the medical instruments supplier’s stock after selling 300 shares during the period. State […] - 2025-03-10 05:41:06

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.